Healthcare personnel more likely to be exposed to COVID-19 at work
Apr 14, 2022
HCP cases were more likely to report healthcare exposures and were less likely to report household/community exposures.
COVID-19 vaccine hesitancy up for racial, ethnic minority healthcare workers
Aug 30, 2021
Vaccine hesitancy was highest among Black and Hispanic or Latino healthcare workers; concerns include side effects and the newness of the vaccine.
30 percent of hospital-based healthcare personnel unvaccinated
Nov 22, 2021
Vaccination coverage was highest among HCP in children’s hospitals, followed by those in short-term acute care hospitals, long-term acute care hospitals, and critical access hospitals (77, 70.1,...
No change found in pattern of adverse events after third COVID-19 shot
Sep 30, 2021
Of the 12,591 individuals who completed a health check-in for all three doses, 79.4 and 74.1% reported local or systemic reactions, respectively.
Adverse events after BNT162b2 do not differ for cancer patients
Feb 08, 2022
Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment.
Abnormal ventilatory patterns common after COVID-19 infection
Dec 09, 2021
Patients with postacute sequelae of SARS-CoV-2 infection also have circulatory impairment and myalgic encephalomyelitis/chronic fatigue.
SARS-CoV-2 reinfection more likely in unvaccinated individuals
Aug 09, 2021
Individuals unvaccinated against COVID-19 were more likely to be reinfected in May to June 2021 after prior infection in 2020.
Almost 30 percent of COVID-19 patients develop ‘long COVID’
May 02, 2022
Factors independently associated with PASC include hospitalization for COVID-19, having diabetes and higher body mass index.
Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.
mRNA-1273 continues to be efficacious at five months
Sep 27, 2021
The efficacy of mRNA-1273, the Moderna vaccine, was 93.2% for preventing COVID-19 illness and 98.2% for preventing severe COVID-19.